BRPI1014887A8 - composição farmacêutica para uso no tratamento de neoplasias e uso de um composto provendo di-hidroartemesinina via dosagem sublingual, transmucosal, bucal ou nasal - Google Patents
composição farmacêutica para uso no tratamento de neoplasias e uso de um composto provendo di-hidroartemesinina via dosagem sublingual, transmucosal, bucal ou nasalInfo
- Publication number
- BRPI1014887A8 BRPI1014887A8 BRPI1014887A BRPI1014887A BRPI1014887A8 BR PI1014887 A8 BRPI1014887 A8 BR PI1014887A8 BR PI1014887 A BRPI1014887 A BR PI1014887A BR PI1014887 A BRPI1014887 A BR PI1014887A BR PI1014887 A8 BRPI1014887 A8 BR PI1014887A8
- Authority
- BR
- Brazil
- Prior art keywords
- buccal
- transmucosal
- pharmaceutical composition
- nasal dosage
- sublingual
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- BJDCWCLMFKKGEE-HVDUHBCDSA-N Dihydroartemesinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(O)[C@@H]4C BJDCWCLMFKKGEE-HVDUHBCDSA-N 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 206010061217 Infestation Diseases 0.000 abstract 1
- 208000016604 Lyme disease Diseases 0.000 abstract 1
- 241000242678 Schistosoma Species 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940057917 medium chain triglycerides Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Otolaryngology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0906971.7A GB2469791B (en) | 2009-04-23 | 2009-04-23 | Transmucosal formulation of compounds providing dihydroartemesinin for use in the treatment of neoplastic disease |
| PCT/GB2009/050415 WO2010122275A1 (en) | 2009-04-23 | 2009-04-23 | Pharmaceutical preparation |
| PCT/GB2010/050672 WO2010122356A1 (en) | 2009-04-23 | 2010-04-23 | Sublingual spray formulation comprising dihydroartemesinin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI1014887A2 BRPI1014887A2 (pt) | 2016-04-19 |
| BRPI1014887A8 true BRPI1014887A8 (pt) | 2019-02-12 |
Family
ID=42244197
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1014887A BRPI1014887A8 (pt) | 2009-04-23 | 2010-04-23 | composição farmacêutica para uso no tratamento de neoplasias e uso de um composto provendo di-hidroartemesinina via dosagem sublingual, transmucosal, bucal ou nasal |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US20120157518A1 (enExample) |
| EP (1) | EP2424523B1 (enExample) |
| JP (1) | JP5795760B2 (enExample) |
| CN (1) | CN102395362B (enExample) |
| AU (1) | AU2010240654C1 (enExample) |
| BR (1) | BRPI1014887A8 (enExample) |
| CA (1) | CA2756925A1 (enExample) |
| DK (1) | DK2424523T3 (enExample) |
| ES (1) | ES2390046T3 (enExample) |
| HR (1) | HRP20120711T1 (enExample) |
| IL (1) | IL215453A (enExample) |
| ME (1) | ME02008B (enExample) |
| MX (1) | MX2011010961A (enExample) |
| MY (1) | MY155646A (enExample) |
| NZ (1) | NZ595469A (enExample) |
| PL (1) | PL2424523T3 (enExample) |
| PT (1) | PT2424523E (enExample) |
| RS (1) | RS52430B (enExample) |
| RU (1) | RU2501550C2 (enExample) |
| SG (1) | SG175162A1 (enExample) |
| SI (1) | SI2424523T1 (enExample) |
| WO (1) | WO2010122356A1 (enExample) |
| ZA (1) | ZA201107088B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0720967D0 (en) * | 2007-10-25 | 2007-12-05 | Protophama Ltd | Anti-material pharmaceutical composition |
| JP2012524771A (ja) * | 2009-04-23 | 2012-10-18 | ロンドンファーマ リミテッド | 中性油を含む舌下用の医薬組成物 |
| EP2943193A2 (en) * | 2013-01-14 | 2015-11-18 | Health Clinics Limited | Cancer drug and uses |
| WO2016083827A1 (en) | 2014-11-27 | 2016-06-02 | Cipla Limited | Pharmaceutical composition comprising an artemisinin derivative for nasal or pulmonary delivery |
| JP2020033304A (ja) * | 2018-08-30 | 2020-03-05 | 医療法人ふじいやさか | 薬剤又はサプリメント、組成物、及び水素供給器の使用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030082107A1 (en) * | 1997-10-01 | 2003-05-01 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| CH692321A5 (de) * | 1997-11-03 | 2002-05-15 | Mepha Ag | Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält. |
| HUP0102851A3 (en) * | 1998-07-14 | 2003-03-28 | Bayer Ag | Antiparasitic artemisinin derivatives (endoperoxides), process for their preparation and pharmaceutical compositions containing them |
| AU2002219472A1 (en) * | 2001-01-02 | 2002-07-16 | Elisabeth Shanahan-Prendergast | Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens |
| MXPA04011808A (es) * | 2002-05-31 | 2005-09-12 | Univ Mississippi | Liberacion transmucosica de canabinoides. |
| RU2004139090A (ru) * | 2002-06-06 | 2005-06-10 | Юниверсити Оф Вашингтон (Us) | Способы применения соединений, подобных артемизинину, для профилактики или задержки возникновения злокачественных опухолей |
| WO2004075921A1 (en) * | 2003-02-26 | 2004-09-10 | Vrije Universiteit Brussel | Inclusion complex of artemisinin or derivates thereof with cyclodextrins |
| US20060084675A1 (en) * | 2004-10-18 | 2006-04-20 | Thomas Efferth | Combined treatment with artesunate and an epidermal growth factor receptor kinase inhibitor |
| US20060233895A1 (en) * | 2005-04-15 | 2006-10-19 | Brown Paul R | Herbal remedy for treating Lyme disease |
| PT1933809E (pt) * | 2005-10-11 | 2012-04-26 | Yissum Res Dev Co | Composições para administração por via nasal |
| CN100418524C (zh) * | 2005-10-26 | 2008-09-17 | 重庆医药工业研究院有限责任公司 | 一种稳定的青蒿素及青蒿素衍生物的药物组合物 |
-
2010
- 2010-04-23 BR BRPI1014887A patent/BRPI1014887A8/pt not_active Application Discontinuation
- 2010-04-23 SI SI201030076T patent/SI2424523T1/sl unknown
- 2010-04-23 CN CN201080017965.1A patent/CN102395362B/zh not_active Expired - Fee Related
- 2010-04-23 EP EP10715337A patent/EP2424523B1/en active Active
- 2010-04-23 CA CA2756925A patent/CA2756925A1/en not_active Abandoned
- 2010-04-23 PL PL10715337T patent/PL2424523T3/pl unknown
- 2010-04-23 PT PT10715337T patent/PT2424523E/pt unknown
- 2010-04-23 RS RS20120393A patent/RS52430B/sr unknown
- 2010-04-23 AU AU2010240654A patent/AU2010240654C1/en not_active Ceased
- 2010-04-23 US US13/265,518 patent/US20120157518A1/en not_active Abandoned
- 2010-04-23 DK DK10715337.1T patent/DK2424523T3/da active
- 2010-04-23 SG SG2011073954A patent/SG175162A1/en unknown
- 2010-04-23 NZ NZ595469A patent/NZ595469A/xx not_active IP Right Cessation
- 2010-04-23 ES ES10715337T patent/ES2390046T3/es active Active
- 2010-04-23 MY MYPI2011005080A patent/MY155646A/en unknown
- 2010-04-23 JP JP2012506584A patent/JP5795760B2/ja not_active Expired - Fee Related
- 2010-04-23 HR HRP20120711AT patent/HRP20120711T1/hr unknown
- 2010-04-23 WO PCT/GB2010/050672 patent/WO2010122356A1/en not_active Ceased
- 2010-04-23 RU RU2011139637/15A patent/RU2501550C2/ru active
- 2010-04-23 MX MX2011010961A patent/MX2011010961A/es active IP Right Grant
- 2010-04-23 ME MEP-2012-393A patent/ME02008B/me unknown
-
2011
- 2011-09-28 ZA ZA2011/07088A patent/ZA201107088B/en unknown
- 2011-10-02 IL IL215453A patent/IL215453A/en active IP Right Grant
-
2015
- 2015-07-30 US US14/813,424 patent/US20160022629A1/en not_active Abandoned
-
2017
- 2017-09-06 US US15/697,240 patent/US20170368023A1/en not_active Abandoned
-
2018
- 2018-10-18 US US16/164,610 patent/US20190142737A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8780201A1 (es) | Derivados de pirasol sustituidos con heteroaril utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogénesis | |
| CR11455A (es) | Compuestos nuevos de hidrocarbono ciclico para el tratamiento de enfermedades | |
| AR053162A1 (es) | Compuesto 5 - oxo - pirrolidin sustituido, composicion farmaceutica que lo comprende y su uso para preparar un medicamento para el tratamiento del glaucoma. | |
| BR112012009376B8 (pt) | composição farmacêutica sólida compreendendo um inibidor de sglt-2 e sua forma de dosagem farmacêutica | |
| ATE473975T1 (de) | Chemische verbindungen | |
| ATE398613T1 (de) | Chemische verbindungen | |
| EA025086B9 (ru) | Производные индоламида и родственные соединения для использования при лечении нейродегенеративных заболеваний | |
| HN2011001256A (es) | Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratmiento o prevencion de diabetes | |
| CR20180339A (es) | INHIBIDORES DE PIRAZOLIL QUINAZOLINA CINASA (Divisional 2012-0576) | |
| CR20110270A (es) | Piriloxi-indoles Inhibidores del VEGF-R2 y Uso de los Mismos para el Tratamiento de Enfermedades | |
| EA201190235A1 (ru) | Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750 | |
| CR10479A (es) | Modulares bencimidazolicos de vr1 | |
| BR112014000792A2 (pt) | compostos de piperidinila para uso como inibidores da tanquirase | |
| UY30282A1 (es) | Compuestos quimicos | |
| EA200801997A1 (ru) | Новые соединения | |
| CL2009000381A1 (es) | Compuestos derivados de tiazol o tiazol-5-carboxamida, inhibidores de la actividad estearoil-coa-desaturasa humana (scd); composicion farmaceutica; y uso para el tratamiento de un trastorno o enfermedad mediada por las enzimas de scd, tal como diabetes, obesidad, enfermedad cardiovascular, lipidos elevados, entre otras. | |
| BRPI0817833A8 (pt) | Composição farmacêutica antimalárica, dispositivo de medicamento de liberação, kits e usos de arteméter, arte-éter ou referida composição | |
| CR10304A (es) | Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos | |
| UY29223A1 (es) | Ácidos fenoxiacéticos sustituidos, composiciones farmacéuticas que los contienen y procesos para su preparación | |
| UA107455C2 (uk) | Похідні індолу як протиракові агенти | |
| UY29079A1 (es) | Acidos fenoxiacéticos sustituidos, composiciones que los contienen, procedimientos de preparación y aplicaciones | |
| BRPI1014887A8 (pt) | composição farmacêutica para uso no tratamento de neoplasias e uso de um composto provendo di-hidroartemesinina via dosagem sublingual, transmucosal, bucal ou nasal | |
| BR112015023878A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| UY29161A1 (es) | Nuevos heterociclos | |
| AR056369A1 (es) | Compuestos derivados de quinazolina y composicion farmaceutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
| B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |